LEADER 01188nam  2200361Ia 450 
001 9910697097203321
005 20230902161651.0
035   $a(CKB)5470000002383925
035   $a(OCoLC)574672443
035   $a(EXLCZ)995470000002383925
100   $a20100326d2009      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eresidual solvents in drug products marketed in the United States
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2009]
215   $a1 electronic resource (6 pages)
300   $a"CMC."
300   $a"November 2009."
517   $aGuidance for industry 
606   $aSolvents$zUnited States
606   $aDrug adulteration$zUnited States
615  0$aSolvents
615  0$aDrug adulteration
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910697097203321
996   $aGuidance for industry$93434577
997   $aUNINA